Valuation (72%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 19.19 | N/A |
| PEG Ratio (TTM) | -4.81 | N/A |
| P/S Ratio (TTM) | 1.47 | N/A |
| P/B Ratio (TTM) | 2.22 | N/A |
| P/FCF Ratio (TTM) | 16.41 | N/A |
| Price to 5YR AVG Earnings Ratio | 27.00 | N/A |
| Price to 5YR AVG FCF Ratio | 29.34 | N/A |
Profitability (50%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 8.00% | N/A |
| ROE (TTM) | 12.07% | N/A |
| Net Profit Margin (TTM) | 7.68% | N/A |
| ROIC 5YR AVG | 15.28% | N/A |
Growth (58%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -3.02% | 60.08% | 45.32% |
| Revenue | -0.85% | 1.88% | 7.45% |
| Net Income | -2.91% | 60.66% | 45.88% |
| Cash Flow | 377.96% | 2.74% | 29.92% |
Health (67%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.59 | N/A |
| Quick Ratio (TTM) | 1.73 | N/A |
| D/E Ratio (TTM) | N/A | N/A |
| Interest Coverage (TTM) | 61.30 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 5.67 | N/A |
| LTL to 5YR AVG FCF | 0.67 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.37% | N/A |